editor speak logo
  • Business Tech
  • Startups & VC
  • Business Insights
  • FutureTech
  • Enterprise & SaaS

FutureTech

NASA x Google: Developing an Autonomous Medical Assistant

Anu Joy Anu Joy
|
Published on November 26, 2025

Keeping crew health becomes more difficult as human spaceflight missions get longer and travel further from Earth. Presently, astronauts on the International Space Station depend on direct contact with Houston without an AI medical assistant, ongoing medical supplies deliveries, and the choice to return home quickly after a six-month term. But this scenario could change shortly as NASA, working with commercial partners like Elon Musk’s SpaceX, gets ready for longer flights intended to send people to Mars and the Moon.

This approaching reality is motivating NASA to gradually improve on-orbit medical care to be more independent from Earth. An AI medical assistant under development with Google is among the first investigations along this line. Designed to help astronauts diagnose and treat medical symptoms in cases where a doctor is absent or communication with Earth is cut off, this revolutionary tool is known as the Crew Medical Officer Digital Assistant (CMO-DA).

Google-NASA developing AI medical assistance

This AI medical assistant is working under the framework of Google Cloud’s Vertex AI, the CMO-DA is a multimodal tool that combines speech, text, and images. Under a fixed-price subscription with Google Public Sector, which covers expenses for cloud services, infrastructure for application development, and model training, the project is being carried out, according to David Cruley, a customer engineer in Google’s Public Sector division. 

NASA owns the app’s source code and has helped to improve the AI medical assistant models. Models created by Google and other outside sources are available via the Google Vertex AI platform. CMO-DA has faced three different scenarios from the partnership: ear pain, flank pain, and an ankle injury. Based on the first assessment, history-taking, clinical judgement, and treatment recommendations, a group of three doctors, one of them an astronaut, assessed the performance of the assistant. 

The evaluation showed a high level of diagnostic accuracy; the treatment strategy for flank discomfort was considered 74% likely to be correct; ear pain, 80%; and ankle damage, 88%. So, the $29 Billion Stock Award given by the Tesla Board is still in Elon Musk’s favor.

RECENT POSTS
Cloud AI Update: Microsoft Leads Cloud Computing Market Boom Toward…
November 26, 2025
$1 Trillion AI Market: AMD Targets Massive Chip Growth Plan
November 26, 2025
SoftBank Sells All Nvidia Stake Worth $5.83B to Boost AI…
November 26, 2025
Gemini Brings Smarter AI Experience on Google TV Streamer
November 26, 2025
Bajaj Finance Shares Drop 8% After Q2 Results as Profit…
November 14, 2025
CATEGORIES
    • Business Insights
    • Business Tech
    • BusinessToday
    • Enterprise & SaaS
    • FutureTech
    • Startups & VC
  • Related Posts
    AMD'S $1T AI VISION
    $1 Trillion AI Market: AMD Targets Massive Chip Growth Plan
    AMD projects its data-center revenue to hit $1 trillion within five years,... Muskan Saini
    Softbank dumps nvidia
    SoftBank Sells All Nvidia Stake Worth $5.83B to Boost AI…
    SoftBank Group has sold its entire $5.83 billion stake in Nvidia, redirecting... Swaraj
    lenskart ipo lists 3 percent lower misses grey market
    Lenskart Shares List at 3% Discount: IPO Falls Short of…
    Lenskart Solutions’ shares debuted 3% below the issue price, disappointing grey market... Muskan Saini
    Elon Musk Wins $1 Trillion
    Musk Wins $1 Trillion: Tesla Shareholders Approve World’s Largest-Ever CEO…
    Tesla shareholders have approved Elon Musk’s record-breaking $1 trillion pay package, tied... Muskan Saini
    editor speak logo

    We deliver fast, accurate news and in-depth analysis, keeping readers updated with unbiased reports across politics, business, sports, and entertainment.

    News Categories
    • FutureTech
    • Business Insights
    • Business Tech
    • Business Today
    • Enterprise & SaaS
    • Startups & VC
  • Important Links
    • About Us
    • Privacy Policy
    • Correction Policy
    • Fact Checking Policy
    • Disclaimer
  • CONTACT
    • info@editorspeak.com

    Copyright © 2026 editorspeak.com